Consensus EirGenix Inc.

Equities

End-of-day quote Taipei Exchange Other stock markets 23:00:00 19/05/2024 BST			5-day change	1st Jan Change
82.5 ^TWD	-0.72%		+2.87%	-17.91%

03-22	EirGenix Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
03-08	EirGenix, Inc. Resolves to Sign the Contract with Clinical CRO and the Relevant Companies for Phase III Clinical Trail of the EG1206A	CI

15b8559ad4f2f.rFrW0Vy5yiapVLdqccfPspQ5PqYSvBZe1LGoGRqDfcs._DaJvwnxuRH9HfY1K5Ws8bkPDs9F-iI8hfrcIHziPKr4A5-FbOGPE9sf1A~c7194e1f5234518472f0c1aa8bdb6b9f

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

82.5 TWD

Average target price

132.5 TWD

Spread / Average Target

+60.61%

High Price Target

135 TWD

Spread / Highest target

+63.64%

Low Price Target

130 TWD

Spread / Lowest Target

+57.58%

Trading Rating

Investor Rating

ESG Refinitiv